🇺🇸 FDA
Patent

US 12018252

Methods and compositions for identifying neoantigens for use in treating cancer

granted A61KA61K38/08A61K38/10

Quick answer

US patent 12018252 (Methods and compositions for identifying neoantigens for use in treating cancer) held by ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY
Grant date
Tue Jun 25 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/08, A61K38/10, A61K38/16, A61K39/0011